Vivos Inc. (OTCMKTS:RDGL) Sees Large Decrease in Short Interest

Vivos Inc. (OTCMKTS:RDGL) was the recipient of a large decrease in short interest in January. As of January 15th, there was short interest totalling 25,300 shares, a decrease of 61.0% from the December 31st total of 64,900 shares. Based on an average trading volume of 3,461,200 shares, the days-to-cover ratio is presently 0.0 days.

Vivos Price Performance

Shares of OTCMKTS RDGL traded down $0.01 during mid-day trading on Wednesday, reaching $0.12. 930,894 shares of the company’s stock were exchanged, compared to its average volume of 1,396,783. The firm has a market capitalization of $52.64 million, a price-to-earnings ratio of -11.90 and a beta of 0.91. The firm has a 50-day moving average price of $0.11 and a two-hundred day moving average price of $0.13. Vivos has a 52 week low of $0.05 and a 52 week high of $0.26.

Vivos Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.